Precision BioSciences, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+5261.1% +$34M
$34M
R&D↓-9.1% -$1M
$14M
D&A↓-24.0% -$109K
$345K
Operating Income↑+2.9% +$608K
$-21M
EBITDA↓-24.0% -$109K
$345K
Interest Expense↓-11.2% -$44K
$348K
Interest Income
—
Tax Provision
—
Net Income
$20M
Operating Margin↓-155283.3pts
-158976.9%
Net Margin
58.9%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
0.0%
Operating Lease Cost↑+0.8% +$4K
$486K
Revenue YoY Variation↑+5352.1pts
5261.1%
Income YoY Variation↑+74.9pts
2.9%
Revenue QoQ Variation↑+262996.9pts
263007.7%
Income QoQ Variation↑+193.6pts
5.5%